Revisiting the blind spot of substandard and fake drugs as drivers of antimicrobial resistance in LMICs

被引:20
作者
Gulumbe, Bashar H. [1 ]
Adesola, Ridwan O. [2 ]
机构
[1] Fed Univ, Fac Sci, Dept Microbiol, Birnin Kebbi 860231, Kebbi State, Nigeria
[2] Univ Ibadan, Fac Vet Med, Dept Vet Med, Ibadan, Oyo State, Nigeria
关键词
AMR; fake drugs; LMICs; substandard drugs; pathogens; resistance;
D O I
10.1097/MS9.0000000000000113
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
One of the most significant risks to public health is ongoing antimicrobial resistance (AMR). Substandard and fraudulent medications, particularly in low- and middle-income countries (LMICs), are thought to have a role in the genesis and spread of AMR. There are numerous reports concerning the availability of subpar pharmaceuticals in developing countries, with no scientific evidence as to what exactly is included in some of the prescriptions supplied there. These counterfeit and inferior pharmaceuticals are a financial burden of up to US$200 billion, causing thousands of patient deaths, endangering both individual and public health,and undermining patient trust in the healthcare system. Poor quality and counterfeit antibiotics are often disregarded as possible causes of AMR in AMR studies. Therefore, we examined the issue of fake drugs in LMICs and its possible links to the emergence and spread of AMR.
引用
收藏
页码:122 / 123
页数:2
相关论文
共 10 条
[1]  
[Anonymous], 2017, Study on the public health & socioeconomic impact of SF medical products
[2]   The need for comprehensive and multidisciplinary training in substandard and falsified medicines for pharmacists [J].
Ferrario, Alessandra ;
Orubu, Ebiowei Samuel F. ;
Adeyeye, Moji Christianah ;
Zaman, Muhammad H. ;
Wirtz, Veronika J. .
BMJ GLOBAL HEALTH, 2019, 4 (04)
[3]   Substandard/Counterfeit Antimicrobial Drugs [J].
Kelesidis, Theodoros ;
Falagas, Matthew E. .
CLINICAL MICROBIOLOGY REVIEWS, 2015, 28 (02) :443-464
[4]   Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries A Systematic Review and Meta-analysis [J].
Ozawa, Sachiko ;
Evans, Daniel R. ;
Bessias, Sophia ;
Haynie, Deson G. ;
Yemeke, Tatenda T. ;
Laing, Sarah K. ;
Herrington, James E. .
JAMA NETWORK OPEN, 2018, 1 (04)
[5]  
Pisani Elizabeth, 2019, Wellcome Open Res, V4, P70, DOI 10.12688/wellcomeopenres.15236.1
[6]  
Shwe Than Nu, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P764
[7]   DRUG QUALITY, A CONTRIBUTOR TO DRUG-RESISTANCE [J].
TAYLOR, RB ;
SHAKOOR, O ;
BEHRENS, RH .
LANCET, 1995, 346 (8967) :122-122
[8]  
WHO, 2022, 1 in 10 medical products in developing countries is substandard or falsified News release
[9]  
World Health Organization, MED PROD AL NO 6 202
[10]   Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance? [J].
Zabala, Guillermo A. ;
Bellingham, Khonsavath ;
Vidhamaly, Vayouly ;
Boupha, Phonepasith ;
Boutsamay, Kem ;
Newton, Paul N. ;
Caillet, Celine .
BMJ GLOBAL HEALTH, 2022, 7 (08)